ArticleHealth care management science2026
Optimizing vaccine site locations while considering travel inconvenience and public health outcomes.
Article in Health care management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
During the COVID-19 pandemic, selecting vaccination sites and allocating limited doses required balancing accessibility, disease control, and fairness. We formulate a multi-objective mixed-integer linear programming model that jointly determines the locations of mega-sites and allocates vaccine doses while explicitly incorporating travel inconvenience, disease dynamics, and equitable distribution. The model incorporates commuting patterns from both residential and workplace origins to more accurately capture population mobility, and employs a tractable objective formulation that proxies key public health goals, enabling efficient and equitable mass vaccination planning. Compared with the solution empirically used in Los Angeles County in 2020, we recommend more dispersed mega-site locations that result in a 26% reduction in travel inconvenience and avert an additional 200 infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.